Myosin Therapeutics

Seed
myosintherapeutics.com Biotech & Healthcare
Total Funding $3M
Latest Round $3M Seed
Last Announced Mar 4, 2025
Investors Undisclosed
Decision Makers 3 Available

About Myosin Therapeutics

Advancing first-in-class therapies by targeting molecular motors (NMII) in oncology and neuroscience. Learn about our clinical trials for GBM, PDAC, and SUD.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Undisclosed
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website myosintherapeutics.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised $3,000,000 · Seed

    fundraisingfox.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Myosin Therapeutics.

Funding History

1 Round
Seed equity · Mar 4, 2025

Founders & Leadership

3

Courtney A. Miller

Founder, Chairperson, CEO

Work email & phone locked Unlock →

Patrick R. Griffin

Founder, Director, CSO

Work email & phone locked Unlock →

Theodore Kamenecka

Founder, Director, CSO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts